Related references
Note: Only part of the references are listed.Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas
Saman S. Ahmadian et al.
OCULAR ONCOLOGY AND PATHOLOGY (2022)
The utility of PRAME staining in identifying malignant transformation of melanocytic nevi
Mary E. Lohman et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
Iris Colour and the Risk of Developing Uveal Melanoma
Laurien E. Houtzagers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Update on uveal melanoma: Translational research from biology to clinical practice (Review)
Miguel A. Ortega et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma
Amy C. Schefler et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care
Emily Z. Keung et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma
Serena Patrone et al.
GENES CHROMOSOMES & CANCER (2018)
Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma
Anne Marie Lane et al.
JAMA OPHTHALMOLOGY (2018)
Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma
Louis Cai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
PRAME Expression in Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
Gulcin Gezgin et al.
JAMA OPHTHALMOLOGY (2017)
Patterns of care and survival outcomes after treatment for uveal melanoma in the post-corns era (20042013): a surveillance, epidemiology, and end results analysis
Yuan James Rao et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2017)
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
Benjamin A. Krantz et al.
CLINICAL OPHTHALMOLOGY (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012)
Krishnaraj Mahendraraj et al.
CLINICAL OPHTHALMOLOGY (2017)
Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma
Johannes A.P. van de Nes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Immunohistochemistry as a Practical Tool in Molecular Pathology
Brandon S. Sheffield
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma
Matthew G. Field et al.
CLINICAL CANCER RESEARCH (2016)
Uveal Melanomas with SF3B1 Mutations A Distinct Subclass Associated with Late-Onset Metastases
Serdar Yavuzyigitoglu et al.
OPHTHALMOLOGY (2016)
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
Matthew G. Field et al.
ONCOTARGET (2016)
Driver Mutations in Uveal Melanoma Associations With Gene Expression Profile and Patient Outcomes
Christina L. Decatur et al.
JAMA OPHTHALMOLOGY (2016)
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma
Loren E. Clarke et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
H. Kalirai et al.
BRITISH JOURNAL OF CANCER (2014)
Prognostic parameters in uveal melanoma and their association with BAP1 expression
T. Huibertus van Essen et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Recent developments in prognostic and predictive testing in uveal melanoma
Matthew G. Field et al.
CURRENT OPINION IN OPHTHALMOLOGY (2014)
The Prognostic Value of Extraocular Extension in Relation to Monosomy 3 and Gain of Chromosome 8q in Uveal Melanoma
Jackelien G. M. van Beek et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study
Swathi Kaliki et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma
Michael D. Onken et al.
OPHTHALMOLOGY (2012)
Higher Percentage of FISH-Determined Monosomy 3 and 8q Amplification in Uveal Melanoma Cells relate to Poor Patient Prognosis
Thomas van den Bosch et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Routes of extraocular extension of uveal melanoma - Risk factors and influence on survival probability
Sarah E. Coupland et al.
OPHTHALMOLOGY (2008)
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer
Mirjam. T. Epping et al.
CANCER RESEARCH (2006)
The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
MT Epping et al.
CELL (2005)
Share Paper
